Lyme disease vaccine (recombinant ospa) Intramuscular and Ramucirumab Intravenous

• Generic Name: lyme disease vaccine
• Dosage Forms: n.a.
• Other Brand Names:

Lyme disease vaccine is an active immunizing agent used to prevent infection by Lyme disease bacteria. It works by causing your body to produce its own protection (antibodies) against the bacteria.

Lyme disease causes rash, fever, weakness, and joint and muscle pain. The disease is caused by bacteria passed to humans by the bite of infected ticks.

The risk of getting tick-borne infections can be lessened by such precautions as wearing long-sleeved shirts and long pants, tucking pants into socks, treating clothing with tick repellent, and checking for and removing attached ticks.

Lyme disease vaccine (recombinant ospa) is no longer commercially available.

• Generic Name: ramucirumab
• Dosage Forms: n.a.
• Other Brand Names: Cyramza

Ramucirumab injection is used alone or together with paclitaxel to treat advanced stomach or gastroesophageal junction cancer (cancer that has already spread) after a patient has received other cancer medicines. It is also used in combination with docetaxel to treat metastatic non-small cell lung cancer (cancer that has already spread) in patients who have received other cancer medicines. Ramucirumab is also used in combination with folinic acid, 5-fluorouracil, and irinotecan (FOLFIRI) to treat metastatic colorectal cancer (cancer that has already spread) in patients who have received other cancer medicines.

Ramucirumab is to be given only by or under the direct supervision of your doctor.